Page 2 - Wound System News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Published: May 03, 2021 Arch” or the “ Company”), developer of novel self-assembling wound care and biosurgical devices, today announced that it has appointed Michael S. Abrams its Chief Financial Officer effective May 10, 2021. In alignment with the Company’s succession plan, Mr. Abrams joins Arch’s financial team today, one week before assuming the role currently held by the Company’s Chief Financial Officer, Richard Davis. Mr. Davis will remain with the Company during a Transition Period, which will end on June 30, 2021, after which he will support the Company in a consulti...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Arch Therapeutics Appoints Michael S. Abrams its Chief Financial Officer Arch Therapeutics, Inc.May 3, 2021 GMT FRAMINGHAM, Mass., May 03, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, today announced that it has appointed Michael S. Abrams its Chief Financial Officer effective May 10, 2021. In alignment with the Company’s succession plan, Mr. Abrams joins Arch’s financial t...

Arch Therapeutics to Present at the H.C. Wainwright BioConnect Conference, January 11 – 14, 2021 FRAMINGHAM, Mass., Jan. 05, 2021 — Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, announced today that it will be presenting at the H.C. Wainwright BioConnect Conference, which will be held January 11-14, 2021. Chief Executive Officer, Terrence W. Norchi, MD, and Chief Financial Officer, Richard Davis, are scheduled to present via webcast, which will be available on-demand as of 6:00 AM ET, Monday...